HUTCHMED (China) Ltd (HCM) KPIs and segments
Close on Nov 16, 2026Market cap $2.57BP/E 5.7Yield –
KPIs & segments
Operating metrics and segments that drive HUTCHMED (China)'s business
HUTCHMED (China)'s revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oncology/Immunology segment($M) | 270 | 267 | 314 | 314 | 317 | 266 | 251 | 298 | 259 | 223 | 176 | 143 | |
Other Ventures segment($M) | 149 | 117 | 156 | 195 | 163 | ||||||||
China($M) | 1,686 | 1,706 | 1,717 | 1,213 | 194 | 1,253 | 170 | 236 | 222 | 226 | 216 | 231 | |
US and others($M) | 50.5 | 47.5 | 59.0 | 61.5 | 26.8 | ||||||||
20 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-07-30.
See a number that looks wrong?